Phio Pharmaceuticals (PHIO) Return on Sales (2012 - 2019)
Phio Pharmaceuticals' (PHIO) quarterly Return on Sales came in at 4.62% in Q4 2019, down 409.0% YoY from 1.49% in Q4 2018, and down 11.15% on a QoQ basis from 4.16% in Q3 2019.
Phio Pharmaceuticals (PHIO) Return on Sales (2012 - 2019) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 8 years of Return on Sales data on file, last reported at 4.62% in Q4 2019.
- Quarterly Return on Sales fell 409.0% year-over-year to 4.62% in Q4 2019, while the trailing twelve-month figure through Dec 2019 was 4.62% (down 409.0% YoY) and the FY2019 annual result came in at 4.24%, down 371.0% from the prior year.
- Return on Sales retreated to 4.62% in Q4 2019, from 4.16% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.26% in Q3 2018 to a low of 13.92% in Q2 2017.
- A 5-year average of 3.22% and a median of 2.44% in 2016 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2017 — Return on Sales sank 1146 bps — and 2018, when it jumped 1359 bps.
- Tracing PHIO's Return on Sales over 5 years: stood at 3.07% in 2015, then sank by 54 bps to 4.73% in 2016, then jumped by 49 bps to 2.42% in 2017, then jumped by 78 bps to 0.53% in 2018, then tumbled by 766 bps to 4.62% in 2019.
- The last three Return on Sales figures came in at 4.62% (Q4 2019), 4.16% (Q3 2019), and 1.04% (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 0.00% |
| 10 | Phio Pharmaceuticals | 13.94 Mn | 13.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -4.62% |
| Sep 30, 2019 | -4.16% |
| Jun 30, 2019 | -1.04% |
| Mar 31, 2019 | -1.32% |
| Dec 31, 2018 | -0.53% |
| Sep 30, 2018 | -0.26% |
| Jun 30, 2018 | -0.33% |
| Mar 31, 2018 | -0.97% |
| Dec 31, 2017 | -2.42% |
| Jun 30, 2017 | -13.92% |
| Dec 31, 2016 | -4.73% |
| Sep 30, 2016 | -4.98% |
| Jun 30, 2016 | -2.46% |
| Mar 31, 2016 | -2.23% |
| Dec 31, 2015 | -3.07% |
| Sep 30, 2015 | -5.81% |
| Jun 30, 2015 | -4.31% |
| Mar 31, 2015 | -0.87% |
| Dec 31, 2014 | -14.46% |
| Sep 30, 2014 | -1.38% |